Epileptogenic activity of folic acid after drug induces SLE (folic acid and epilepsy)

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 80, Issue 1, 1998, Pages 75-78

  Eros, Erika ^a   Géher, Pál ^b   Gömör, Béla ^b   Czeizel, Andrew E ^a  

^a National Institute of Public Health Budapest   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Drug induced SLE; Epilepsy; Fetal death; Folic acid supplementation; Pregnancy

Indexed keywords

CARBAMAZEPINE; FOLIC ACID; MULTIVITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; EPILEPTOGENESIS; FEMALE; FETUS DEATH; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0345188614     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00095-5     Document Type: Article

References (32)

1. Czeizel AE, Dudás I Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 327:1992;1832-1835.
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the MRC Vitamin Study. Lancet 1991;338:131-137.
3. Czeizel AE Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J. 306:1993;1645-1648.
4. Czeizel AE Limb-reduction defects and folic acid supplementation. Lancet. 345:1995;932.
5. Czeizel AE Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet. 62:1996;179-183.
6. Li DK, Daling JR, Mueller BAet al. Periconceptional multivitamin use in relation to the risk of congenital urinary tract abnormalities. Epidemiology. 6:1995;212-218.
7. Shaw GM, O'Malley CD, Wasserman CRet al. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 59:1995;536-545.
8. Botto LD, Khoury MJ, Mulinare J, Erickson JD Periconceptional multivitamin use and the occurrence of conotruncal heart defects. Results from a population-based case-control study. Pediatrics. 98:1996;911-917.
9. Shaw GM, Lammer EJ, Wassermann CRet al. Risks of orofacial clefts in children born to women using multivitamin containing folic acid periconceptionally. Lancet. 345:1995;393-396.
10. Yang O, Khoury MJ, Mulinare J, Erickson DJ Does periconceptional multivitamin use reduce the risk for limb deficiency in offspring. Epidemiology. 8:1997;157-161.
11. Czeizel AE Primary prevention of birth defects by periconceptional care, including multivitamin supplementation. Bailliere's Clin Obstet Gynecol. 9:1995;417-430.
12. Schwartz SO, Kaplan SR, Armstrong BE The long-term evaluation of folic acid in treatment of pernicious anemia. J Lab Clin Med. 35:1950;894-898.
13. Czeizel AE, Dudás I, Métneki J Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final results. Arch Gynecol Obstet. 255:1994;131-139.
14. Rubin RL, Joslin FG, Tan EM An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies. J Immunol Methods. 63:1983;359-366.
15. McCarty GA, Valencia DW, Fritzler MJ. Antinuclear antibodies: contemporary techniques and clinical application to connective tissue diseases. New York: Oxford University Press, 1984:1-96.
16. Chanarin I, Laidlow J, Lughridge LW, Mollin DL Megaloblastic anaemia due to phenobarbitone. The convulsant action of therapeutic doses of folic acid. Br Med J. 1:1960;1099-1102.
17. Chien LT, Krundiesk CL, Scott CW, Butterworth CE Jr. Harmful effect of megadoses of vitamins: electroencephalogram abnormalities and seizures induced by intravenous folate in drug-treated epileptics. Am J Clin Nutr. 28:1975;51-58.
18. Strauss RG, Bernstein R Folic acid and dilantin antagonism in pregnancy. Obstet Gynecol. 44:1975;345-348.
19. Boss GR, Ragsdale RA, Lettner A, Seegmiller JE Failure of folic acid (pteroylgutamic acid) to affect hyperuricemia. J Lab Clin Med. 96:1980;783-789.
20. Dansky LV, Andermann E, Rosenblatt Det al. Anticonvulsants, folate levels and pregnancy outcome: a prospective study. Ann Neurol. 27:1987;176-182.
21. Baxter MG, Miller AA, Webster RA Some studies on the convulsant action of folic acid. Br J Pharmacol. 48:1973;350-351.
22. Olney JW, Fuller TA, de Gubareff T, Labruyere J Intrastriatal folic acid mimics the distant but not focal brain damaging properties of kainic acid. Neurosci Lett. 25:1981;185-191.
23. Hommes OR, Obbens EAMT, Wijfeels CCB Epileptogenic activity of sodium-folate and the blood-brain barrier in the rat. J Neurol Sci. 19:1973;63-71.
24. Biale Y, Lewenthal H Effects of folic acid supplementation on congenital malformation due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod Biol. 18:1984;211-216.
25. Condemi JJ The autoimmune diseases. J Am Med Assoc. 268:1992;2882-2892.
26. Yerbi MS Teratogenic effect of antiepileptic drugs: what do we advise patients. Epilepsia. 38:1997;957-958.
27. Czeizel AE, Bod M, Halász P Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epidemiol. 8:1992;122-127.
28. Cseh I, Halász P, Gáti I. National centre for epileptic pregnancies. Int J Gynecol Obstet 1991;29 Suppl 44.
29. Rand JH, Wu XX, Andree HAMet al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med. 337:1997;154-160.
30. Czeizel AE, Tomcsik M, Tímár L Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynecol. 90:1997;195-201.
31. Czeizel AE. Acute toxicity of folic acid in pregnant women. Teratology (submitted).
32. US Department of Health and Human Service FDA 21 CFR food labelling: health claims and label statement: folate and neural tube defects Proposed rule and final rule Federal Register, Washington DC, 1996.